Skip to main content

Table 2 Compares between baseline characteristics and effect of treatment after 2 months among participants

From: Daily intake of 30 mg duloxetine is effective in decreasing premature ejaculation severity: a prospective randomized placebo-controlled cross over clinical trial

 

Group

P value

A

B

Median

Minimum

Maximum

Median

Minimum

Maximum

IIEF-5a

24

22

33

24

22

25

0.621e

AIPE baselineb

19

9

20

19.5

8

30

0.41e

IELT baseline (Sec)c

60

30

120

60

30

120

0.577e

Male SQOL baselined

20

15

30

21

16

33

0.294e

AIPE after treatmentb

26

9

34

19.5

8

30

 < 0.001e

IELT after treatment (Sec)c

180

30

240

60

30

120

 < 0.001e

Male SQOL after treatmentd

45

18

55

21

16

33

 < 0.001e

  1. aIIEF-5 the international index of erectile function
  2. bAIPE the Arabic index of premature ejaculation
  3. cIELT Intravaginal ejaculatory latency time
  4. dMale SQOL (sexual quality of life questionnaire- male version) before and after treatment in both placebo and treatment groups
  5. eP value was calculated using Mann Whitney U test
Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190